Your browser doesn't support javascript.
loading
Phase 2 study of nilotinib in pediatric patients with Philadelphia chromosome-positive chronic myeloid leukemia.
Hijiya, Nobuko; Maschan, Alexey; Rizzari, Carmelo; Shimada, Hiroyuki; Dufour, Carlo; Goto, Hiroaki; Kang, Hyoung Jin; Guinipero, Terri; Karakas, Zeynep; Bautista, Francisco; Ducassou, Stéphane; Yoo, Keon Hee; Zwaan, Christian Michel; Millot, Frédéric; Aimone, Paola; Allepuz, Alex; Quenet, Sara; Hourcade-Potelleret, Florence; Hertle, Sabine; Sosothikul, Darintr.
  • Hijiya N; Department of Pediatrics, Columbia University Medical Center, New York, NY.
  • Maschan A; Dmitrii Rogachev Federal Research Center for Pediatric Hematology, Oncology and Immunology, Moscow, Russia.
  • Rizzari C; Department of Pediatrics, Pediatric Hematology Oncology Unit, University of Milano Bicocca, Monza e Brianza per il Bambino e la sua Mamma Foundation, Azienda Socio Sanitaria Territoriale Monza, Monza, Italy.
  • Shimada H; Department of Pediatrics, Keio University School of Medicine, Tokyo, Japan.
  • Dufour C; IRCCS Hematology Unit, Istituto Giannina Gaslini, Genoa, Italy.
  • Goto H; Division of Hematology/Oncology, Kanagawa Children's Medical Center, Yokohama, Japan.
  • Kang HJ; Department of Pediatrics, Seoul National University College of Medicine, Seoul National University Cancer Research Institute, Seoul National University Children's Hospital, Seoul, South Korea.
  • Guinipero T; Department of Pediatrics, Division of Pediatric Hematology/Oncology/Bone Marrow Transplantation, Nationwide Children's Hospital, The Ohio State University, Columbus, OH.
  • Karakas Z; Department of Pediatrics, Hematology/Oncology Unit, Istanbul University, Istanbul School of Medicine, Istanbul, Turkey.
  • Bautista F; Department of Pediatric Oncology, Hospital Niño Jesus, Madrid, Spain.
  • Ducassou S; Centre Hospitalier Universitaire (CHU) Bordeaux, Oncologie Hématologie Pédiatrique, Université de Bordeaux, Unité INSERM U1218, Bordeaux, France.
  • Yoo KH; Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
  • Zwaan CM; Department of Pediatric Oncology/Hematology, Erasmus Medical Center-Sophia Children's Hospital, Rotterdam, The Netherlands.
  • Millot F; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
  • Aimone P; Innovative Therapies for Children with Cancer Consortium, Utrecht, The Netherlands.
  • Allepuz A; Unité d'Onco-Hématologie Pédiatrique, Clinical Investigation Center 1402 INSERM, CHU de Poitiers, Poitiers, France.
  • Quenet S; Novartis Pharma AG, Basel, Switzerland.
  • Hourcade-Potelleret F; Novartis Pharma AG, Basel, Switzerland.
  • Hertle S; Clinical Development and Analytics.
  • Sosothikul D; Pharmacokinetics Sciences, and.
Blood ; 134(23): 2036-2045, 2019 12 05.
Article en En | MEDLINE | ID: mdl-31511239
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Pirimidinas / Cromosoma Filadelfia / Leucemia Mielógena Crónica BCR-ABL Positiva Tipo de estudio: Clinical_trials / Diagnostic_studies / Observational_studies / Prognostic_studies Límite: Adolescent / Child / Child, preschool / Female / Humans / Male Idioma: En Año: 2019 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Pirimidinas / Cromosoma Filadelfia / Leucemia Mielógena Crónica BCR-ABL Positiva Tipo de estudio: Clinical_trials / Diagnostic_studies / Observational_studies / Prognostic_studies Límite: Adolescent / Child / Child, preschool / Female / Humans / Male Idioma: En Año: 2019 Tipo del documento: Article